noncontrast computed tomography, computed tomography angiography, and computed tomography perfusion. Treatment decisions were made by the neuroendovascular and stroke teams based on the clinical symptoms and neuroimaging data about the viability and eloquence of the involved territories. In general, patients with persistent disabling deficits despite intravenous tPA and evidence of proximal or distal occlusion accounting for their symptoms were taken to angiography. We did not specifically wait for intravenous tPA treatment response to minimize time to endovascular treatment. In nearly all cases of anterior circulation occlusions, a balloon guide catheter was used. The overall treatment strategy (stent-retriever versus thromboaspiration versus intra-arterial tPA) was at the discretion of the treating neurointerventionist depending on vessel size and location as well as the degree of vascular tortuosity. Distal occlusions were defined as any occlusion of the anterior cerebral artery (ACA), posterior cerebral artery (PCA), or any occlusion at or distal to the middle cerebral artery (MCA)-M3 opercular segment, which is classically defined as a segment between the circular sulcus of the insula and the cortical surface. 12 On angiography, this was defined as any occlusion distal to the first vertical MCA branch on anterior-posterior angiography, which has been previously been used to use to define the M2 segment. 10 We further divided the distal intracranial occlusions into primary occlusions, where the distal vessel was the original target of the ET, and rescue occlusions, where after ET for a LVOS a distal occlusion was visualized in the previously involved territory or in an uninvolved territory that was then treated with ET.
Clinical Variables and Measures of Outcome
Demographics, clinical, radiological/angiographic, procedural, and outcome variables were analyzed for the distal occlusion group. The objective of the study was to describe the treatment of distal intracranial occlusions with emphasis on safety and reperfusion efficacy. Parenchymal hematoma (PH) was defined per ECASS (European Cooperative Acute Stroke Study) criteria and included PH-1 and PH-2. 13 Reperfusion was graded according to the modified Treatment In Cerebral Ischemia (mTICI) scale.
14 This study was approved by the local Institutional Review Board with a waiver of informed consent.
Statistical Analysis
Continuous variables are reported as mean±SD or median (interquartile range), as appropriate. Categorical variables are reported as proportions. Statistical analyses were performed using IBM SPSS Statistics 23 (IBM-Armonk, NY).
Results
Out of a total ET population of 949 patients during the study period, distal occlusions were treated in 69 patients. Demographic and outcome data are detailed in Table 1 . The mean age was 66.7±15.8 and 57% of the patients were male. Patients (29 [42%]) received intravenous tPA. The median preprocedure National Institutes of Health Stroke Scale was 18 (interquartile range, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] .
Demographic information for the total anterior circulation thrombectomy population, for those with proximal arterial occlusion alone, and for those with distal occlusion can be found in Table 1 .
The distal occlusion was the primary treatment location in 45 patients, in 23 patients the distal occlusion was treated as a rescue strategy after successful treatment of a proximal LVOS, and 1 patient had a primary ACA occlusion and an MCA-M2 occlusion treated, and then underwent a rescue MCA-M3 thrombectomy after initial reperfusion.
The locations of the cases are detailed in Table 2 . The most common treatment modalities used were stent-retrievers (n=37, 54%), intra-arterial tPA (n=36, 52%), and thromboaspiration (n=31, 45%). Complete or near complete reperfusion (mTICI 2b-3) of the distally occluded territory was achieved in 57 cases (83%). Complete (mTICI 3) reperfusion was achieved in 31 cases (45%). Complete or near complete (mTICI 2b-3) reperfusion was attained in 23 of 31 (74%) cases where thromboaspiration was used and 34 of 37 (92%) cases where a stent-retriever was used. The rate of distal near or complete reperfusion (mTICI 2b-3) was 90% in the ACA occlusions and 65% in the MCA territory.
Overall, there were 5 (7%) cases of any PH. However, 2 of the PHs were in patients with both a MCA-M1 and an ACA occlusion, and both of these hemorrhages were in the MCA territory. Thus, only 3 PHs (4%) occurred in the territory of the treated distal occlusion. Of these 3 PHs, 2 were following primary MCA-M3 occlusions treated with full stent-retriever reperfusion (mTICI 3); the remaining 1 case followed a rescue PCA occlusion treated with full stent-retriever reperfusion (mTICI 3). Both MCA-M3 occlusions received intravenous r-tPA and one of the MCA-M3 occlusions received 4 mg of intra-arterial r-tPA infusion before stent-retriever thrombectomy. There were no cases of contrast extravasation or vessel perforation noted on the angiographic images. There were no cases where the distal occlusion thrombectomy resulted in a more proximal occlusion. At 90 days, 21 patients (30%) had a modified Rankin Scale score of 0 to 2 and 14 (20%) had died. Table 1 details the 90-day outcomes by type of lesion treated. 
Discussion
Although much emphasis has been rightly placed on ET therapy for LVOS, it is not only large vessels which can cause significant patient morbidity. For example, in terms of functional independence, a distal MCA-M3 occlusion causing aphasia (Figures 1 and 2 ) or an ACA occlusion ( Figure 3 ) causing monoplegia can be devastating for a patient. 15 In addition, the desire to examine the efficacy of more distal occlusions is a natural extension of a recent growing literature on MCA-M2 thrombectomies. 16 These studies have shown improved outcomes with successful thrombectomy, along with similar rates of reperfusion compared with MCA-M1 thrombectomy. These data combined with advances in technology, which allow the interventionalist to work in smaller vessels, makes the case for potential ET in cases of potentially disabling distal occlusion strokes.
It is widely accepted that intravenous tPA is particularly effective in the treatment of distal arterial occlusions. However, there is a paucity of data about not only the natural history but also the treatment effect of reperfusion therapies in the specific context of angiographically-proven distal occlusions. In the IMS-III trial (Interventional Management of Stroke III), there were only 5 subjects with occlusions involving M3, M4, or ACA. 17 Similarly, in the MR CLEAN trial (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands), there were only 3 ACA occlusions and no described M3 or M4 occlusions. 2 Most of the remaining of endovascular trials have excluded patients with distal occlusions. This relative lack of data are compounded by the fact that distal occlusions have a highly pleomorphic clinical presentation, depending on the size and location of the involved vessel. It is important to note that the clinical severity (National Institutes of Health Stroke Scale) for this series is higher than expected in typical isolated distal occlusions. The reasons for that are multifactorial but include some degree of selection bias, as cases with distal occlusions with lower clinical severity were more likely to be managed medically. Many of these cases included rescue thrombectomy for intraprocedural distal embolization during the treatment of primary proximal occlusions. Other cases involved multiple vascular territories (eg, ACA and MCA), resulting in significant compromise of collateral flow and high clinical severity. Moreover, some isolated distal occlusions may lead to dramatic clinical presentations closely resembling the more proximal occlusions. For instance, ACA occlusions typically present with contralateral leg weakness and sensory changes but may also cause more severe symptoms including hemiparesis, motor neglect, and apraxia because of involvement the supplementary motor area, corpus callosum, anterior diencephalon, and deep structures, as well as abulia, transcortical aphasias, and mutism.
Occlusion of a large M3 trunk can cause different combinations of symptoms including hemiplegia, aphasia, neglect, and hemianopia. Proximal PCA occlusions involving the perforator vessels origin can cause not only hemianopia but also highly disabling upper brain stem and thalamic syndromes. Finally, some of the cases of isolated distal occlusion may have had more severe presentation as a result of an initially more proximal thrombus that subsequently migrated to more distal arteries either spontaneously or as a consequence of intravenous tPA treatment. For similar reasons, the 90-day functional outcomes in this study were considerably worse than expected from a series of distal occlusions, which speaks not only to the potential gravity of some of these occlusions, but also calls for further regimented study of these patients.
Although primary distal occlusions are important, there is also a potentially significant role for rescue distal occlusion thrombectomy. Studies have shown the rate of procedurerelated ACA occlusion as a result of ICA or MCA thrombectomy to be between 4% to 11%. 2, 6, 18 Additionally, as the criteria 19 and DEFUSE-3 (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke), there will be a concomitant increase in the need for potential rescue thrombectomy of embolization to a new territory.
Our series demonstrates that these distal thrombectomies are safe to perform. Our 7% rate of PH is within the 2% to 8% range of symptomatic hemorrhage in the landmark thrombectomy clinical trials. Although this may be high in comparison to what would be expected for simple distal occlusions, the findings should be analyzed in the context of our treated population given their high initial clinical severity (median National Institutes of Health Stroke Scale score of 18) and case complexity often involving initially proximal or multiple occlusions. Notably, the hemorrhage rate was only 4% in the territory of the distal thrombectomy and no PHs occurred in cases of isolated primary ACA or PCA occlusions. 20, 21 Additionally, the fact that there were no cases of vessel perforation and extravasations add to the potential safety of working in distal, more tortuous arteries. The safety data are important to note because many of the recent articles on small stent-retrievers and thromboaspiration catheters included mainly MCA-M2 patients and not a majority of MCA-M3 as we have included. 8, 22, 23 Additionally, our rate (83%) of reperfusion over multiple generations of devices is fairly similar to other smaller series involving distal occlusion. 6, 8, 18 It is important to note that our data along with other series demonstrate the efficacy of recanalization with both newer generation aspiration catheters as well as smaller stent-retrievers.
Despite the overall favorable safety data herein presented, it is important to acknowledge that a careful risk-benefit assessment becomes particularly critical when considering the treatment of distal occlusions. As compared with their proximal counterparts, distal arteries are smaller in caliber, have thinner walls, and are typically more tortuous. All these factors increase the treatment risk profile. At the same time, distal arteries supply a smaller tissue territory which lessens the benefit of reperfusion. However, we consider that ET in the distal vascular bed represents a very reasonable option for territories of high eloquence, in particular, if there is evidence of a significantly disabling clinical deficit, poor angiographic collateral flow, or there is absence of recovery on the intraprocedural neurological examination after proximal reperfusion alone. Notably, we tend to specifically avoid the use of mechanical devices in the distal superior division branches given their greater tortuosity as compared with the ACA, PCA, or inferior division MCA branches. In cases of significant tortuosity, the usage of intra-arterial thrombolytics is typically preferred. We also think vasospasm prevention with intra-arterial infusion of vasodilators such as nicardipine or milrinone might be of benefit when treating smaller vessels.
Our study has several limitations mostly inherent to its retrospective design and relatively small sample size. This is further limited by the heterogeneous presentations that range from isolated distal occlusions to multiterritorial occlusions to rescue thrombectomy, which makes any conclusion about factors associated with independent patient outcome difficult to delineate. In addition, we do not have a control group of distal occlusions treated medically to serve as a comparison for the endovascularly treated patients. Our study represents the largest series of endovascularly treated distal occlusions to the best of our knowledge to date, which we hope will lead to future studies including a randomized clinical trial.
Conclusions
This retrospective study demonstrates the ability to endovascularly treated distal intracranial occlusions safely and with acceptable radiographic results. These results need to be corroborated by larger prospective controlled studies.
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